The trajectory of Viagra presents a nuanced case for investors in the drug sector. While initially a phenomenal success, producing billions, the intellectual property expiration and the subsequent arrival of off-brand https://pharma877698.yomoblog.com/49130834/sildenafil-and-big-pharma-a-risky-bet